{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:47:39Z","timestamp":1794491259069,"version":"4.9.1"},"reference-count":29,"publisher":"American Chemical Society (ACS)","issue":"7","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2023,7,3]]},"DOI":"10.1021\/acs.molpharmaceut.3c00208","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T03:29:14Z","timestamp":1684985354000},"page":"3578-3588","source":"Crossref","is-referenced-by-count":11,"title":["Estimating Unbound Drug Concentrations in Simulated Human Lung Fluid: Relevance to Lung Antibiotic PKPD"],"prefix":"10.1021","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7359-5350","authenticated-orcid":true,"given":"Janneke","family":"Keemink","sequence":"first","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Cantrill","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Riboulet","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Jurmanovi\u0107","sequence":"additional","affiliation":[{"name":"Selvita Ltd., 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Pavlovski","sequence":"additional","affiliation":[{"name":"Selvita Ltd., 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Bissantz","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02309-18"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2017.09.019"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02307-18"},{"key":"ref4\/cit4","unstructured":"EMA.  Guideline on the Use\nof Pharmacokinetics and Pharmacodynamics in the Development of Antimicrobial\nMedicinal Products, in EMA\/CHMP\/594085\/2015; European Medicines Agency: London, 2016."},{"key":"ref5\/cit5","unstructured":"FDA.  Antibacterial Therapies\nfor Patients With an Unmet Medical Need for the Treatment of Serious\nBacterial Diseases Guidance for Industry, F.a.D.A. U.S. Department\nof Health and Human Services, Center for Drug Evaluation and Research\n(CDER), Editor, 2017."},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.12.004"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00133-06"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.2165\/11594090-000000000-00000"},{"key":"ref9\/cit9","unstructured":"Enlo-Scott, Z. Understanding Local Respiratory Toxicity and Bioavailability of Inhaled Pesticides in an Occupational Exposure Setting, Institute of Pharmaceutical Science; King\u2019s College London, 2021; p 233."},{"key":"ref10\/cit10","unstructured":"Bicer, E. Compositional Characterisation of Human Respiratory Tract Lining Fluids for the Design of Disease Specific Simulants, Analytical & Environmental Sciences Division School of Biomedical & Health Sciences; King\u2019s College London, 2014; p 428."},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2018.08.006"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-017-2169-4"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2014.12.009"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1021\/ci00053a005"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1021\/ci700018y"},{"key":"ref16\/cit16","unstructured":"CLSI Methods for Dilution\nAntimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Clinical and Laboratory Standards Institute (CLSI): Wayne, Pa, 2015."},{"key":"ref17\/cit17","unstructured":"CLSI Performance\nStandards\nfor Antimicrobial Susceptibility Testing; 24th Informational Supplement; Clinical and Laboratory Standards Institute (CLSI): Wayne, PA, 2015."},{"key":"ref18\/cit18","unstructured":"NCCLS Methods\nfor Determining\nBactericidal Activity of Antimicrobial Agents; National Committee for Clinical Laboratory Standards: Villanova, Pa, 1999."},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1038\/nature22308"},{"key":"ref20\/cit20","unstructured":"WHO.  WHO Publishes List of\nBacteria for which\nNew Antibiotics are Urgently Needed, 2017. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. (date of access May 10, 2023).w"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9210-3"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2014.03.013"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(86)90662-3"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.09.004"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-018-2551-x"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24477"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00106803"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.2.281"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1955"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.3c00208","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.3c00208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T16:05:41Z","timestamp":1688400341000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.3c00208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,3]]}},"alternative-id":["10.1021\/acs.molpharmaceut.3c00208"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00208","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00208.s001","asserted-by":"subject"}]},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]}}}